发明名称 Integrated insulin delivery system with continuous glucose sensor
摘要 Systems and methods for integrating a continuous glucose sensor 12, including a receiver 14, a medicament delivery device 16, a controller module, and optionally a single point glucose monitor 18 are provided. Integration may be manual, semi-automated and/or fully automated.
申请公布号 US9457146(B2) 申请公布日期 2016.10.04
申请号 US201314144373 申请日期 2013.12.30
申请人 DexCom, Inc. 发明人 Dobbles John Michael;Kamath Apurv Ullas;Mahalingam Aarthi;Brauker James H.
分类号 A61M5/172;A61B5/145;A61M5/142;G06F19/00;A61B5/00;A61M5/00;A61M5/178;A61M5/30;A61M11/00;A61M15/00 主分类号 A61M5/172
代理机构 Knobbe Martens Olson & Bear, LLP 代理人 Knobbe Martens Olson & Bear, LLP
主权项 1. An integrated system for managing diabetes, the system comprising: a continuous glucose sensor, wherein the continuous glucose sensor is configured to substantially continuously measure a glucose concentration in a host, and to provide sensor data associated with the glucose concentration in the host; and an insulin delivery device configured to deliver insulin to the host as determined by a controller module, wherein the controller module is configured to: continuously instruct the basal insulin therapy at a pre-programmed insulin delivery rate responsive to the sensor data meeting one or more predetermined basal criteria;adaptively calculate a bolus insulin therapy responsive to the sensor data meeting a present or predicted hyperglycemic glucose value or range of values, wherein the bolus insulin therapy is calculated based on the sensor data; andimmediately terminate insulin therapy responsive to the sensor data meeting one or more predetermined off criteria.
地址 San Diego CA US